This company has shut down. Alucent Biomedical is no longer operating — its last tracked round was a Venture - Series Unknown in 2023.
Explore the Startup GraveyardAlucent Biomedical is a biomedical company that develops a combination drug-device therapy for the treatment of vascular diseases.
Alucent Biomedical has raised $11.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2023.
Alucent Biomedical is headquartered in Salt Lake City, United States.
Alucent Biomedical is a biomedical company that develops a combination drug-device therapy for the treatment of vascular diseases.
Alucent Biomedical is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Alucent Biomedical — Funding & Investors." VCBacked, April 20, 2023, https://www.vcbacked.co/company/alucent-biomedical. Accessed August 17, 2026.
VCBacked. (2023). Alucent Biomedical — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/alucent-biomedical
{{cite web |title=Alucent Biomedical — Funding & Investors |url=https://www.vcbacked.co/company/alucent-biomedical |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated